Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1347 of 5804
-
New Gear-Shifting wheelchair aims to save shoulders
Symptom relief Recruiting nowOver one million Americans rely on their upper extremities for manual wheelchair propulsion. Shoulder overuse injuries are prevalent among manual wheelchair users and these injuries often result in shoulder pain. Severe shoulder pain can lead some wheelchair users to transition f…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
New pill aims to tame Crohn's Flare-Ups
Disease control Recruiting nowThis is a Phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of 3 active dose regimens of MORF-057 in adult study participants with moderately to severely active Crohn's disease (CD).
Phase: PHASE2 • Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for stem cell transplant patients: simpler drug combo may reduce severe side effects
Disease control Recruiting nowGraft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-CSH). Recently, in the context of semi-identical (=haploidentical) HLA donors, but also of compatible HLA donors, the use of cyclophosphamide (CY) administered in…
Phase: PHASE2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Firefighter trainees get mental health training to prevent PTSD and depression
Prevention ENROLLING_BY_INVITATIONThe goal of this clinical trial is to determine if a peer-delivered emotion regulation training (Brief-Unified Protocol) workshop is effective for preventing posttraumatic stress and other psychological health symptoms in firefighter trainees. The main questions it aims to answer…
Phase: NA • Sponsor: Baylor Research Institute • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Long COVID exercise breakthrough? new study tests ways to boost energy
Symptom relief CompletedThis is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key …
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New shot could shrink nasal polyps and ease breathing
Disease control CompletedThis is a parallel, Phase 2, 2-arm, multicenter, randomized, double-blind, placebo-controlled, proof-of-concept study for treatment of CRSwNP. The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with subcutaneous lunsekimig in adult pa…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug BMS-986470 enters human trials for sickle cell disease
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics, pH and food effect, and preliminary efficacy of BMS-986470 in healthy volunteers and participants with sickle cell disease.
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New diabetes shot every two weeks could rival weekly drug
Disease control OngoingThe aim of the study is to compare the efficacy and safety of two JY09 doses versus dulaglutide as add-on therapy to metformin in participants with type 2 diabetes mellitus (T2DM)
Phase: PHASE3 • Sponsor: Beijing Dongfang Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:59 UTC
-
Can a common drug help cancer patients regain appetite?
Symptom relief Recruiting nowThis phase II trial tests how well olanzapine works in managing cancer cachexia in patients experiencing esophagogastric, hepatopancreaticobiliary, colorectal, or lung cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the b…
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Can a common breast cancer drug slow uterine sarcoma?
Disease control Recruiting nowThis is a clinical trial to test letrozole in patients with uterine leiomyosarcoma. The main question is will treatment with letrozole extend progression-free survival in patients. Patients will receive 2/5 mg of letrozole daily.
Phase: PHASE2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Can ruxolitinib stop a deadly transplant complication in kids?
Disease control Recruiting nowThis phase II trial tests how well ruxolitinib with tacrolimus and methotrexate work to prevent the development of graft versus host disease in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplant for acute myeloid leukemia, acute lymphoblastic l…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Brain zap may stop chemo nerve damage
Prevention Recruiting nowCohort 1: To track the onset and progression of a condition called chemotherapy-induced peripheral neuropathy (CIPN). Cohort 2: To track the onset and progression of a condition called chemotherapy-induced peripheral neuropathy (CIPN) and to test a certain type of experimental n…
Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
New mRNA vaccine trial hopes to stop pancreatic cancer return
Disease control Recruiting nowThis study primarily aims to assess the safety and tolerability of XP-004 personalized mRNA vaccines encoding tumor neoantigens combined with PD-1 inhibitor as adjuvant therapy for chemotherapy-intolerant patients following radical pancreatic cancer resection. Secondary objectiv…
Phase: EARLY_PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Hidden lung disease? online quiz could lead to Life-Changing treatment
Diagnosis Recruiting nowOur research group has found that Canadians with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) have increased respiratory symptoms and worse health-related quality of life. The investigators recently developed and validated an on-line questionnaire to accura…
Phase: NA • Sponsor: Ottawa Hospital Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Cholesterol drug may supercharge immune cells against prostate cancer
Disease control Recruiting nowTo test the hypothesis that intensive cholesterol lowering (iCL) therapy has anti-tumor immune modulating activity, the investigators will conduct an open-label, single-arm phase II trial in prostate cancer patients who are in active surveillance and undergoing a planned surveill…
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug aims to shield heart muscle after major attack
Disease control Recruiting nowThis is an exploratory, randomized, double-blind, multicentre, placebo-controlled study of RTP-026. The study population will consist of men and women with documented evidence of ST-elevation myocardial infarction (STEMI) referred to primary Percutaneous Coronary Intervention (P…
Phase: PHASE2 • Sponsor: ResoTher Pharma • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Gut bacteria could help revive immunotherapy in lung cancer
Disease control Recruiting nowAs treatment options are limited following progression on anti PD-(L)1 and platinum-based chemotherapy, we propose this trial for patients who have failed to respond or have shown intolerance to standard therapies or for whom no appropriate therapies are known to provide clinical…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Hope for liver disease: new drug trial targets PBC symptoms
Disease control OngoingOpen-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for liver cancer patients with cirrhosis: safety trial launches
Disease control OngoingThe purpose of this study is to assess the safety of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in participants with unresectable, locally advanced or metastatic hepatocellular carcinoma (HCC) with Child-pugh B7 or B8 cirrhosis.
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a headset tame ADHD without meds? new trial tests brain zaps in kids
Symptom relief OngoingA randomized, sham-controlled, double-blind clinical trial to examine the safety and effectiveness of tRNS on unmedicated pediatric patients (7-12 years) with ADHD. Subjects will undergo either tRNS or sham treatment for 10 days during a two-week period in a home-simulated enviro…
Phase: NA • Sponsor: Innosphere • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC